奥地利生物技术公司Marinomed向欧洲投资银行担保423 840欧元的可兑换债券。 Austrian biotech firm Marinomed secures €423,840 convertible bond with European Investment Bank.

奥地利生物技术公司Marinomed Biotech AG与欧洲投资银行(EIB)签署了一份具有约束力的期限表,以获得价值423,840欧元的可兑换债券。 Austrian biotech firm Marinomed Biotech AG has signed a binding term sheet with the European Investment Bank (EIB) for a convertible bond worth €423,840. 该债券最多可兑换84 768股,每股5欧元。 The bond could convert into up to 84,768 shares at €5 each. 该公司还在探索第二次增加现金资本,但取决于投资者谈判和董事会的批准。 The company is also exploring a second cash capital increase, contingent on investor negotiations and board approvals.